Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 9 von 764

Details

Autor(en) / Beteiligte
Titel
Serum Opacity Factor Normalizes Erythrocyte Morphology in Scarb1-/- Mice in an HDL-Free Cholesterol-Dependent Way
Ist Teil von
  • Journal of lipid research, 2023-11, Vol.64 (11), p.100456-100456, Article 100456
Ort / Verlag
United States: Elsevier Inc
Erscheinungsjahr
2023
Quelle
MEDLINE
Beschreibungen/Notizen
  • Compared to wild-type (WT) mice, high-density lipoprotein (HDL)-receptor-deficient (Scarb1-/-) mice have higher plasma levels of free cholesterol (FC)-rich HDL and exhibit multiple pathologies associated with a high mol% FC in ovaries, platelets, and erythrocytes which are reversed by lowering HDL. Bacterial serum opacity factor (SOF) catalyzes the opacification of plasma by targeting and quantitatively converting HDL to neo HDL (HDL remnant), a cholesterol ester-rich microemulsion, and lipid-free APOA1. SOF delivery with an adeno-associated virus (AAVSOF) constitutively lowers plasma HDL-FC and reverses female infertility in Scarb1-/- mice in an HDL-dependent way. We tested whether AAVSOF delivery to Scarb1-/- mice will normalize erythrocyte morphology in an HDL-FC dependent way. We determined erythrocyte morphology and FC content (mol%) in three groups—WT, untreated Scarb1-/- (control), and Scarb1-/- mice receiving AAVSOF—and correlated these with their respective HDL-mol% FC. Plasma-, HDL- and tissue-lipid compositions were also determined. Plasma- and HDL-mol% FC positively correlated across all groups. Among Scarb1-/- mice, AAVSOF treatment normalized reticulocyte number, erythrocyte morphology and erythrocyte-mol% FC. Erythrocyte-mol% FC positively correlated with HDL-mol% FC and with both the number of reticulocytes and abnormal erythrocytes. AAVSOF treatment also reduced FC of extravascular tissues to a lesser extent. HDL-FC spontaneously transfers from plasma HDL to cell membranes. AAVSOF treatment lowers erythrocyte-FC and normalizes erythrocyte morphology and lipid composition by reducing HDL-mol% FC. [Display omitted]
Sprache
Englisch
Identifikatoren
ISSN: 0022-2275
eISSN: 1539-7262
DOI: 10.1016/j.jlr.2023.100456
Titel-ID: cdi_doaj_primary_oai_doaj_org_article_9ab64245fa4046f68267f451fcd9985d

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX